NervGen Pharma Corp. (TSXV: NGEN)
Canada
· Delayed Price · Currency is CAD 3.000
-0.130 (-4.15%)
Dec 20, 2024, 3:59 PM EST
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of CAD 210.92 million as of December 20, 2024. Its market cap has increased by 110.63% in one year.
Market Cap
210.92M
Enterprise Value
190.05M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.00
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 32.67M to 210.92M, an increase of 545.59%. That is a compound annual growth rate of 38.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 210.92M | 31.06% |
| Dec 29, 2023 | 160.94M | 71.42% |
| Dec 30, 2022 | 93.89M | -24.19% |
| Dec 31, 2021 | 123.84M | 58.14% |
| Dec 31, 2020 | 78.31M | 36.12% |
| Dec 31, 2019 | 57.53M | 76.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch + Lomb Corporation | 9.11B |
| Bausch Health Companies Inc. | 3.95B |
| WELL Health Technologies Corp. | 1.77B |
| dentalcorp Holdings Ltd. | 1.64B |
| Tilray Brands, Inc. | 1.64B |
| Curaleaf Holdings, Inc. | 1.59B |
| Sienna Senior Living Inc. | 1.31B |
| Cronos Group Inc. | 1.07B |